NCT01064882

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 104 (actual)
• Sponsor: Allergan · Industry
• Sex: Female
• Age: 30 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence

Conditions

• Eyelash Hypotrichosis

Interventions

Type	Name	Description
DRUG	bimatoprost ophthalmic solution 0.005%	One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margins (where the eyelashes meet the skin)
DRUG	bimatoprost ophthalmic solution 0.015%	One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margins (where the eyelashes meet the skin)
DRUG	bimatoprost ophthalmic solution 0.03%	One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margins (where the eyelashes meet the skin)

Timeline

• Start date: 2010-03-01
• Primary completion: 2010-07-01
• Completion: 2010-07-01
• First posted: 2010-02-09
• Last updated: 2011-12-09
• Results posted: 2011-12-09

Locations

1 site across 1 country: United States